Urinary lipid profile of patients with coronavirus diseases 2019
The coronavirus diseases 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ongoing. Over 490 million people have been infected with this virus worldwide. Although many patients present with lower respiratory symptoms, some may progress to acute respir...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-09-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.941563/full |
| _version_ | 1798001294325055488 |
|---|---|
| author | Misato Kida Tatsuro Nakamura Koji Kobayashi Tatsuo Shimosawa Takahisa Murata |
| author_facet | Misato Kida Tatsuro Nakamura Koji Kobayashi Tatsuo Shimosawa Takahisa Murata |
| author_sort | Misato Kida |
| collection | DOAJ |
| description | The coronavirus diseases 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ongoing. Over 490 million people have been infected with this virus worldwide. Although many patients present with lower respiratory symptoms, some may progress to acute respiratory distress syndrome and even multi-organ damage. Therefore, there is an urgent need to establish treatment and management methods for this infectious disease. Here, we comprehensively analyzed urinary lipid mediators and their metabolites to identify non-invasive biomarkers that reflect the disease status of COVID-19 patients. We diagnosed 16 patients by polymerase chain reaction (PCR) analysis, who presented with mild-to-moderate symptoms, including fever and cough, between May and October 2020 in Japan, and collected their urine samples. Using mass spectrometry, we analyzed the lipid metabolites in these urine samples. In all the urine samples from the patients, 21 types of fatty acids and their metabolites were consistently detected in the samples among the 214 metabolites which were analyzed. Interestingly, urinary levels of fatty acids, docosahexaenoic acid was increased by approximately 3-fold in patients with COVID-19 compared to those in healthy subjects. Metabolites of major proinflammatory lipid mediators, PGE2, TXA2, and PGF2α, were also detected at significantly higher levels in the urine of patients with COVID-19. These observations suggest that urinary lipids can reflect the inflammatory status of patients with COVID-19, which can be a useful index to manage this disease. |
| first_indexed | 2024-04-11T11:35:05Z |
| format | Article |
| id | doaj.art-c3f97fcc93fd4e7fa9591e9700f8e3c4 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-04-11T11:35:05Z |
| publishDate | 2022-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-c3f97fcc93fd4e7fa9591e9700f8e3c42022-12-22T04:26:01ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-09-01910.3389/fmed.2022.941563941563Urinary lipid profile of patients with coronavirus diseases 2019Misato Kida0Tatsuro Nakamura1Koji Kobayashi2Tatsuo Shimosawa3Takahisa Murata4Department of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, JapanDepartment of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, JapanDepartment of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, JapanDepartment of Clinical Laboratory, International University of Health and Welfare, Chiba, JapanDepartment of Animal Radiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, JapanThe coronavirus diseases 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ongoing. Over 490 million people have been infected with this virus worldwide. Although many patients present with lower respiratory symptoms, some may progress to acute respiratory distress syndrome and even multi-organ damage. Therefore, there is an urgent need to establish treatment and management methods for this infectious disease. Here, we comprehensively analyzed urinary lipid mediators and their metabolites to identify non-invasive biomarkers that reflect the disease status of COVID-19 patients. We diagnosed 16 patients by polymerase chain reaction (PCR) analysis, who presented with mild-to-moderate symptoms, including fever and cough, between May and October 2020 in Japan, and collected their urine samples. Using mass spectrometry, we analyzed the lipid metabolites in these urine samples. In all the urine samples from the patients, 21 types of fatty acids and their metabolites were consistently detected in the samples among the 214 metabolites which were analyzed. Interestingly, urinary levels of fatty acids, docosahexaenoic acid was increased by approximately 3-fold in patients with COVID-19 compared to those in healthy subjects. Metabolites of major proinflammatory lipid mediators, PGE2, TXA2, and PGF2α, were also detected at significantly higher levels in the urine of patients with COVID-19. These observations suggest that urinary lipids can reflect the inflammatory status of patients with COVID-19, which can be a useful index to manage this disease.https://www.frontiersin.org/articles/10.3389/fmed.2022.941563/fullCOVID-19lipidomicsproinflammatory lipid mediatorsmetabolitesurine analysis |
| spellingShingle | Misato Kida Tatsuro Nakamura Koji Kobayashi Tatsuo Shimosawa Takahisa Murata Urinary lipid profile of patients with coronavirus diseases 2019 Frontiers in Medicine COVID-19 lipidomics proinflammatory lipid mediators metabolites urine analysis |
| title | Urinary lipid profile of patients with coronavirus diseases 2019 |
| title_full | Urinary lipid profile of patients with coronavirus diseases 2019 |
| title_fullStr | Urinary lipid profile of patients with coronavirus diseases 2019 |
| title_full_unstemmed | Urinary lipid profile of patients with coronavirus diseases 2019 |
| title_short | Urinary lipid profile of patients with coronavirus diseases 2019 |
| title_sort | urinary lipid profile of patients with coronavirus diseases 2019 |
| topic | COVID-19 lipidomics proinflammatory lipid mediators metabolites urine analysis |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2022.941563/full |
| work_keys_str_mv | AT misatokida urinarylipidprofileofpatientswithcoronavirusdiseases2019 AT tatsuronakamura urinarylipidprofileofpatientswithcoronavirusdiseases2019 AT kojikobayashi urinarylipidprofileofpatientswithcoronavirusdiseases2019 AT tatsuoshimosawa urinarylipidprofileofpatientswithcoronavirusdiseases2019 AT takahisamurata urinarylipidprofileofpatientswithcoronavirusdiseases2019 |